|
US 12,290,530 B2 |
|
| Peptides displayed by HLA for use in immunotherapy against different types of cancers |
| Ricarda Hannen, Tuebingen (DE); Jens Hukelmann, Tuebingen (DE); Florian Koehler, Tuebingen (DE); Daniel Johannes Kowalewski, Tuebingen (DE); Heiko Schuster, Tuebingen (DE); Oliver Schoor, Tuebingen (DE); Michael Roemer, Tuebingen (DE); Chih-Chiang Tsou, Houston, TX (US); and Jens Fritsche, Tuebingen (DE) |
| Assigned to Immatics Biotechnologies GmbH, Tübingen (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on Mar. 8, 2024, as Appl. No. 18/599,888. |
| Application 18/599,888 is a division of application No. 17/576,866, filed on Jan. 14, 2022, granted, now 11,957,716, issued on Apr. 16, 2024. |
| Claims priority of provisional application 63/272,878, filed on Oct. 28, 2021. |
| Claims priority of provisional application 63/137,985, filed on Jan. 15, 2021. |
| Claims priority of application No. 102021100809.3 (DE), filed on Jan. 15, 2021. |
| Prior Publication US 2024/0358755 A1, Oct. 31, 2024 |
| Int. Cl. A61K 35/17 (2025.01); A61K 39/00 (2006.01); A61K 40/11 (2025.01); A61K 40/42 (2025.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C12N 5/0783 (2010.01) |
